Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-6.32M.
ENTERPRISE VALUE (EV)
$-6.32M
Aprea Therapeutics, Inc.
Market Cap
$8.28M
Enterprise Value (EV)
$-6.32M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Aprea Therapeutics, Inc. (APRE) | $8.28M | $-6.32M |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | $19.63M |
| DataMEDS AI, Inc. (MEDS)vs › | $8.58M | $38.74M |
| GT Biopharma, Inc. (GTBP)vs › | $7.94M | $2.98M |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | N/A |
| Longeveron Inc. (LGVN)vs › | $7.46M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.14M | $7.25M |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.37M | $5.18M |
| HeartSciences Inc. (HSCS)vs › | $7.34M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.22M | $2.26M |
Market Cap
$8.28M
Total Debt
$0.00
Cash
$14.60M
Enterprise Value
$-6.32M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
